IVASS - Institute for Insurance Supervision
IVASS - Institute for Insurance Supervision
05/15/2024 | Press release | Distributed by Public on 05/15/2024 02:13
AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
IVASS - Institute for Insurance Supervision
05/15/2024 | Press release | Distributed by Public on 05/15/2024 02:13
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact